Leidos falls after BofA cuts rating, PT

Leidos Holdings

17/06/2026 12:18

** Defense contractor Leidos' shares LDOS.N fall 2.1% to $111.20 premarket
** BofA cuts PT to $125 from $200, still representing a 10% upside to the stock's last close
** Brokerage downgrades rating to "neutral" from "buy", to reflect increasing pressure across LDOS' "once blooming" healthcare portfolio 
** "While we anticipate LDOS will be able to leverage its existing capabilities and network to win business in managed health, increasing competition in the healthcare sector limits future upside."
** Eight of 19 brokerages rate the stock "buy" or higher and 11 "hold"; their median PT is $179
** Up to Tuesday's close, stock had fallen 37% YTD

 (Reporting by Aatreyee Dasgupta ((Aatreyee.Dasgupta@thomsonreuters.com;)))
 ((Medha.Singh@thomsonreuters.com; +91 80 6210 0592; X, formerly Twitter: @medhasinghs;))